Latest News

 Filter by Provider

Recursion Pharmaceuticals (NASDAQ:RXRX) outlined its strategy, clinical pipeline and partnership progress at Morgan Stanley’s Global Healthcare Conference, with CEO and President Najat Khan emphasizing the company’s shift toward an end-to-end, AI-enabled drug discovery and development platform. Kha

The market has a history of reacting the wrong way to economic data, but that doesn't mean you can ignore it.

Hyperliquid may be soaring, but how much longer can it hold on to its market-leading position?

With resilient businesses, solid financial performance, and visible growth opportunities, these five TSX stocks offer compelling opportunities for long-term investors.

Helus Pharma Chief Executive Officer Michael Halstead said the company expects a pivotal Phase III readout for its HLP003 program in adjunctive major depressive disorder in the fourth quarter, describing the data as a key near-term catalyst for the company’s mental health treatment pipeline. Speaki

Loblaw is a core holding candidate for a long-term TFSA. Canadians can consider dollar-cost averaging into a position over time to reduce market-timing risk.

The investment bank's stock is in a prime position to head higher.

Canada’s dividend pioneer is the ultimate anchor stock and forever holding in a TFSA.

Nvidia is guiding for 70% top-line growth in its next fiscal year, but the chipmaker has regularly proven too conservative with its guidance in the past.

The software maker is growing faster than ever, yet its shares sit about where they were a year ago. So is the stock finally reasonably priced?

Aurora Innovation (NASDAQ:AUR) is preparing to expand its autonomous-trucking operations through a second-generation hardware rollout, a planned transition toward a driver-as-a-service model and additional manufacturing relationships, Co-founder and CEO Chris Urmson said at the Morgan Stanley Laguna

The unlocking of SpaceX shares is reshaping the communications sector.

The sale of 5,578 shares appears to be a routine transaction.

Yields are rising, and investors are selling REITs, opening up an opportunity to buy reliable, high-yield dividend stocks for long-term investors.

It's one of four key sector holdings in the company's portfolio.

This expensive quantum computing stock isn't growing as fast as it seems.

Jazz Pharmaceuticals (NASDAQ:JAZZ) executives outlined the company’s oncology growth strategy, early commercial progress for recently launched therapies and business-development priorities during the Morgan Stanley Global Healthcare Conference. Chumi Khurana, senior vice president of U.S. Oncology

The index has climbed in 34 of the last 41 fourth quarters. The seven misses are the part worth studying.

Coca-Cola isn't cheap, but it is executing well in a difficult market and has an incredible dividend history.

Investors are growing increasingly concerned about AI-powered threats.

Pfizer's rebound is well underway.

SpaceX stock has rebounded nicely since its prior sell-off, but can the momentum last until its next earnings report?

Meta has fallen behind the other frontier labs recently, but that may have changed with the introduction of the Muse app.

WW International (NASDAQ:WW) executives outlined the company’s efforts to reposition its weight-management business around behavioral support, telehealth and GLP-1 medications, following a restructuring that substantially reduced its debt burden. Speaking at Morgan Stanley’s healthcare conference,

Looking back at how five stocks picked specifically to beat the market over just the next year have now fared 10 years later.

The business multiplied over the decade. The stock's price-to-earnings multiple mostly didn't.

Arista Networks and Vertiv Holdings give investors two long-term ways to play the AI boom beyond the crowded chip trade.

DoorDash and Viking are leaders in delivery and cruises, offering investors growth at a reasonable price.

After decades of spinoffs and separations of various parts, GE Aerospace is now trending toward integration.

A look at what would happen if history repeats itself.

Online slot games have become a familiar form of digital entertainment for adults who enjoy casino-style gaming. With mobile-friendly platforms, simple int

Jazz Pharmaceuticals (NASDAQ:JAZZ) outlined development and commercial plans for its oncology, epilepsy and sleep franchises during a discussion with Deutsche Bank analyst David Hoang, emphasizing the expansion potential of HER2-targeted therapy Ziihera and ongoing lifecycle work for EPIDIOLEX. Zii

Fashion for men continues to evolve, but comfort and versatility remain two of the most important qualities people look for when choosing everyday clothing

The Canary Staked TRX ETF could be well timed if the Tron network continues growing.

Yesterday the U.S. Fed raised interest rates for the first time in three years. This was not unexpected. What might it mean for medium-term gold and silver

SK Hynix boasts a 44% net margin and trades at 5.8x forward P/E, while AMD commands a 63x multiple despite stronger growth.

How bottlenecks in the power generation space could benefit companies such as Emphase and Bloom Energy.

There are much better AI stocks to invest in right now.

Main Street Capital has generated significant income for investors since its IPO.

The administration can't fight the bond market forever.

Stanley Black & Decker (NYSE:SWK) CEO Chris Nelson said the company is progressing against three priorities: strengthening its core brands, improving operational execution and accelerating innovation. Speaking at the Morgan Stanley 14th Annual Laguna Conference, Nelson said the company reported

One company is riding explosive AI connectivity demand with triple-digit growth. The other is navigating smartphone headwinds while building promising new businesses in automotive and data centers.

Constellation Energy has the largest nuclear fleet in the country and should benefit from rising power demand in the decades ahead.

The IEA expects energy demand from AI data centers in 2030 to exceed Japan's current energy demand.

Investing is one of the very few things where the rewards increase with less work.

Hotels are continuously filled with people every day. In lobbies, hallways, dining halls, entrance areas and even outdoors, the flooring material faces muc

One generates revenue but faces fraud lawsuits and customer concentration risk. The other has no sales yet but substantial cash reserves.

Among these out-of-favor restaurant stocks, go with the one with the stronger value proposition.

Synchrony Financial (NYSE:SYF) Chief Financial Officer Brian Wenzel said the company was seeing high-single-digit purchase-volume growth roughly 2.5 months into the third quarter, consistent with the approximately 8% growth reported during the second quarter. Speaking at an investor event, Wenzel s

Rigetti Computing has been very volatile over the past few years.